company-logo

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Shanghai Labway Clinical Laboratory Dividend Announcement

Shanghai Labway Clinical Laboratory announced a annually dividend of ¥0.30 per ordinary share which will be made payable on 2023-06-20. Ex dividend date: 2023-06-20
Shanghai Labway Clinical Laboratory annual dividend for 2023 was ¥0.30
Shanghai Labway Clinical Laboratory's trailing twelve-month (TTM) dividend yield is -%
Shanghai Labway Clinical Laboratory's payout ratio for the trailing twelve months (TTM) is -79.44%

Shanghai Labway Clinical Laboratory Dividend History

Ex-Div dateDividend amountDividend typePay date
2023-06-20¥0.30annually2023-06-20
2022-04-29¥0.30annually2022-04-29

Shanghai Labway Clinical Laboratory Dividend per year

Shanghai Labway Clinical Laboratory Dividend Yield

Shanghai Labway Clinical Laboratory current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Shanghai Labway Clinical Laboratory stock? Use our calculator to estimate your expected dividend yield:

Shanghai Labway Clinical Laboratory Financial Ratios

P/E ratio-23.81
PEG ratio-0.25
P/B ratio2.49
ROE-10.25%
Payout ratio-79.44%
Current ratio3.45
Quick ratio2.93
Cash Ratio1.17

Shanghai Labway Clinical Laboratory Dividend FAQ

Does Shanghai Labway Clinical Laboratory stock pay dividends?
Shanghai Labway Clinical Laboratory does not currently pay dividends to its shareholders.
Has Shanghai Labway Clinical Laboratory ever paid a dividend?
No, Shanghai Labway Clinical Laboratory has no a history of paying dividends to its shareholders. Shanghai Labway Clinical Laboratory is not known for its dividend payments.
Why doesn't Shanghai Labway Clinical Laboratory pay dividends?
There are several potential reasons why Shanghai Labway Clinical Laboratory would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Shanghai Labway Clinical Laboratory ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Shanghai Labway Clinical Laboratory has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Shanghai Labway Clinical Laboratory a dividend aristocrat?
Shanghai Labway Clinical Laboratory is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Shanghai Labway Clinical Laboratory a dividend king?
Shanghai Labway Clinical Laboratory is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Shanghai Labway Clinical Laboratory a dividend stock?
No, Shanghai Labway Clinical Laboratory is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Shanghai Labway Clinical Laboratory stocks?
To buy Shanghai Labway Clinical Laboratory you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Shanghai Labway Clinical Laboratory stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.